Skip to content

Human Brainwave (Gamma Wave PSD) Improvement and usability evaluation test for 'Brain spa'

Human Brainwave (Gamma Wave PSD) Improvement and usability evaluation test for 'Brain spa'

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009766
Enrollment
20
Registered
2024-09-06
Start date
2024-01-25
Completion date
Unknown
Last updated
2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Korea Biomedical Research Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects aged 20 to 64 who have difficulty sleeping normally. 2. Healthy applicants without any physical illnesses. 3. Subjects who have listened to a detailed explanation of the study and have voluntarily signed the informed consent form. 4. Subjects who are able to be followed up during the study period.

Exclusion criteria

Exclusion criteria: 1. Subjects who are pregnant, breastfeeding, or planning to become pregnant within the next six months. 2. Subjects who are continuously taking medications that can affect brain function. 3. Subjects who are receiving medical treatment or taking medication for psychiatric disorders. 4. Subjects who have participated in a similar study within the past month. 5. Subjects who have used cosmetics or medications with the same or similar efficacy on the study area within the month prior to the study. 6. Subjects with chronic debilitating diseases (e.g., asthma, diabetes, hypertension). 7. Subjects who are continuously taking contraceptives, antihistamines, or anti-inflammatory drugs. 8. Subjects who are employees of this clinical research institute. 9. Subjects who are deemed unsuitable for the study by the investigator's judgment.

Design outcomes

Secondary

MeasureTime frame
subjective sleep quality;sleep latency;sleep duration;sleep efficiency;sleep disturbances;sleeping medication use;daytime dysfunction

Primary

MeasureTime frame
Gamma Oscillations Power Spectral Density;Pittsburgh Sleep Quality Index, PSQI

Countries

Korea, Republic of

Contacts

Public ContactHyo Je Ahn

Korea Biomedical Research Institute

dksgywp1@gmail.com+82-31-606-7185

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026